<BEGIN>
Thermo Fisher Says Its COVID-19 Tests Can Detect Omicron Variant
Thermo Fisher Scientific Inc (NYSE:TMO) said that its COVID-19
diagnostic tests can accurately detect the new coronavirus variant Omicron.
* The Omicron variant has more than 30 mutations in the spike protein alone.
* Last week, the World Health Organisation (WHO) classified the Omicron
variant as a SARS-CoV-2 "variant of concern," saying it may spread more quickly
than other forms.
* Thermo Fisher's TaqPath COVID-19 assays can report accurate results even
if one of the gene targets is impacted by a mutation.
* Read Next: Thermo Fisher's COVID-19 Response Revenue Accounts For 22% In
Q3 Sales, Boosts FY21 Outlook.
* Specific genotyping assays to detect the Omicron variant are being
developed for Thermo Fisher's TaqMan Mutation Panel.
* The panel, which is currently used for research purposes, already has a
menu of over 50 assays to assess confirmed COVID-19 cases for the presence of
known variants and mutations.
* Also See: Qiagen Says Its COVID-19 PCR Tests Can Detect The New South
African Variant.
* Price Action: TMO shares traded higher by 1.04% at $645.40 during the
premarket session on the last check Monday.
(TS:TMO)
<END>
Социальные закладки